Continuous glucose monitoring (CGM): Clinical Trials

3 trials of Continuous glucose monitoring (CGM), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Terminated 1, Unknown 1

Follow Continuous glucose monitoring (CGM): new trials by email Literature Review of Continuous glucose monitoring (CGM) trials Research Report on Continuous glucose monitoring (CGM)

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Anti Diabetic Agents in the Hospital
Oral Anti-diabetes Drugs alone, Basal bolus insulin, Supplemental insulin - Diabetes Mellitus
Phase 4TerminatedEmory University852020-08-072026-08-31
Atheroma Progression and Vulnerability Under Continuous Glucose Monitoring
continuous glucose monitoring (CGM) - Coronary Atherosclerosis
Phase 4UnknownNational Cerebral and Cardiovascular Center, Japan902019-03-012020-09-22
Treatment of Hypoglycemia Following Gastric Bypass Surgery
Glucobay (acarbose), Januvia (sitagliptin), Verapamil HEXAL (verapamil) - Hypoglycemia, Obesity
Phase 4CompletedZealand University Hospital112015-10-012018-03-07

Conditions studied

Coronary Artery Disease (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Hyperglycemia (1)  ·  Hypoglycemia (1)  ·  Obesity (1)

Sponsors

Emory University (1)  ·  National Cerebral and Cardiovascular Center, Japan (1)  ·  Zealand University Hospital (1)

Countries

Japan (1)  ·  United States (1)

Top investigators

Caroline C Gormsen, M.D. (1)  ·  Maya Fayfman, MD (1)  ·  Yu Kataoka, MD (1)

Results publications

PMID 31737515, PMID 31907828

NIH funding

K23DK124647 (1)